CN109010695A - A kind of drug rehabilitation therapy for synthetic drug - Google Patents

A kind of drug rehabilitation therapy for synthetic drug Download PDF

Info

Publication number
CN109010695A
CN109010695A CN201811110306.7A CN201811110306A CN109010695A CN 109010695 A CN109010695 A CN 109010695A CN 201811110306 A CN201811110306 A CN 201811110306A CN 109010695 A CN109010695 A CN 109010695A
Authority
CN
China
Prior art keywords
drug
radix
patient
rehabilitation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811110306.7A
Other languages
Chinese (zh)
Inventor
黄科荣
谷洪振
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zexu Voluntary Drug Rehabilitation Center In Fuzhou High-Tech Zone
Original Assignee
Zexu Voluntary Drug Rehabilitation Center In Fuzhou High-Tech Zone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zexu Voluntary Drug Rehabilitation Center In Fuzhou High-Tech Zone filed Critical Zexu Voluntary Drug Rehabilitation Center In Fuzhou High-Tech Zone
Priority to CN201811110306.7A priority Critical patent/CN109010695A/en
Publication of CN109010695A publication Critical patent/CN109010695A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237—Notopterygium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Radiology & Medical Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acoustics & Sound (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

The invention discloses a kind of drug rehabilitation therapies for synthetic drug, including quick toxin expelling, promotion cranial nerve cell functional rehabilitation, control mental symptom, psychotherapy and preventing suction again treatment；This drug rehabilitation therapy is a kind of quick toxin expelling, toxin expelling is thorough, treatment is comprehensive, MDT multidisciplinary synthesis cure curative for effect, it passes through unique then Xu's secret recipe, and combine infusion, acidification urine and herbal fumigation method that patient's body toxin is quickly discharged, it repairs simultaneously because consuming illegal drugs impaired cranial nerve cell, treated by psychotherapy again, heart addiction can be effectively released, helps the drug addiction patient later period that can obtain better that rehabilitation, raising preventing suction again rate can effectively release heart addiction, it helps the drug addiction patient later period that can obtain better rehabilitation, improves preventing suction again rate.

Description

A kind of drug rehabilitation therapy for synthetic drug
Technical field
The invention belongs to treat drug addiction field, and in particular to a kind of drug rehabilitation therapy for synthetic drug.
Background technique
Drug dependence is a kind of state of mind caused by drug and body interaction, sometimes also includes body shape State.It show it is a kind of mandatory continuous periodically with the behavior of the medicine and other reactions, in order that the spirit for experiencing it to be gone to imitate It answers, or in order to avoid uncomfortable due to caused by off-drug.The intension of present habituation has covered substance (drug) habituation With behavior habituation.The core feature of habituation be patient clearly know factum it is harmful but can not automatic control, and drug addiction is pair Drugs can make one to form the narcotics of addiction addiction and psychotropic substances generate dependence, and drug addict continues and thirsts for obtaining poison periodically Product, this serious hope is overriding, can produce so-called withrawal symptom " painful as hell " once interrupting and taking drugs, becomes extremely certainly Private obtains drugs by fair means or foul, and to society, to family completely without the sense of duty, honor or disgrace is all forgotten, and harm is personal, family and society.
Drug rehabilitation refer to drug addict give up suck, the bad habit and drug addiction of shoot up.To drug addict carry out drug addiction treatment, one As should include three phases: detoxification -- rehabilitation -- step into again society guidance；Typically now using natural drug withdrawal, drug and Non-drug gives up method.
Summary of the invention
The object of the present invention is to provide a kind of drug rehabilitation therapy for synthetic drug, the therapy can reach quick toxin expelling, The effect that toxin expelling is thoroughly, treatment is comprehensive and relapse rate is low.
To achieve the above object, the technical solution adopted by the present invention is that: a kind of drug rehabilitation therapy for synthetic drug, including Following steps:
(1) quick toxin expelling: it is the 1st week, clearing heat and detoxicating by Traditional Chinese medicinal prescription, and infusion, acidification urine and herbal fumigation method are combined, Vivotoxin is thoroughly rapidly excluded by the liver of drug addiction patient, kidney, blood and skin；
(2) promote cranial nerve cell functional rehabilitation: the 2-3 weeks, giving drug addiction patient rush cognition drug improved its cognitive function, together When give gangliosides 40mg/ days, and be aided with traditional Chinese herbal decoction, restore drug addiction patient and be damaged cranial nerve cell function；
(3) it controls mental symptom: the 2-4 weeks, giving haloperidol 5-10mg intramuscular injection, anti-essence according to drug addiction patient mental's symptom Refreshing medicine is oral, after the disappearance of its mental symptom, gives mood stabilizers, antidepression to the drug addiction patient for the disturbance of emotion occur Disease and anti anxiety agent object after disease amelioration, then pass through the cranial nerve cell of transcranial magnetic stimulation treatment patient；
(4) it psychotherapy: while above-mentioned treatment, according to the motivation that drug addiction patient consumes illegal drugs, takes targetedly psychological Treatment, motivation intensive treatment, cognitive behavioral therapy, reduction injury technology, family marriage treatment, individual drug rehabilitation consulting, group's ring Poison consulting and meditation technology make drug addiction patient from the muddled stage of drug rehabilitation gradually successively excessively to the preparation stage is pondered, rank of taking action Section, consolidation phase, termination phase.
(5) preventing suction again is treated: after above-mentioned treatment, drug addiction patient changes because consuming illegal drugs caused Neurobiology, Substantially it is addressed, then after family psychotherapy and individual mind treatment, so that drug addiction patient is preferably re-established interpersonal Relationship, the sense of duty that founds a family, social responsibility.
Preferably, Traditional Chinese medicinal prescription described in step (1) is that radix bupleuri 18-23g, Radix Paeoniae Alba 18-23g, Fructus Aurantii 18-23g, toast is sweet Careless 18-23g, Rhizoma Et Radix Notopterygii 20-25g rhizoma corydalis 15-20g and monkshood 15-20g high fire decoct 40min, add datura flower 3-8g, Huang Even 5-10g, Radix Astragali 15-20g, Radix Angelicae Sinensis 15-20g, RHIIZOMA DIOSCOREAE from Henan of China 15-20g, five spirit 10-15g, cow-bezoar 5-10g, scorpio 3-8g, deer horn glue 10-15g, unipods golden pheasant 5-10g, Radix Curcumae 10-15g and olibanum 10-15g high fire decoct 30min, and last small fire decocts 15min, takes 300ml supernatant A, then by the above-mentioned Chinese medicine decocted, small fire decocts 30min again, takes 300ml supernatant B, it then will be upper Clear liquid A and supernatant B mixing obtains.
Preferably, infusion solution used in being infused in step (1) is nutrition infusion.
Preferably, traditional Chinese medicine ingredients are by weight in herbal fumigation method described in step (1) are as follows: Radix Astragali 15-20g, the root of fangji 10-15g, Rhizoma Atractylodis Macrocephalae 15-20g, ramulus cinnamomi 15-20g, Radix Paeoniae Alba 15-20g, Radix Glycyrrhizae 10-15g, pawpaw 30-35g, Rhizoma Et Radix Notopterygii 15-20g, safflower 10-15g, peach kernel 10-15g, radix bupleuri 15-20g, Radix Curcumae 15-20g, Radix Angelicae Sinensis 15-20g and ramulus mori 15-20g.
Preferably, promoting cognition drug in step (2) is one of huperzine, Piracetam and Cerebrolysin.
Preferably, traditional Chinese medicine ingredients are by weight in traditional Chinese herbal decoction described in step (2) are as follows: Radix Angelicae Sinensis 15-20g, radix bupleuri 18- 23g, Poria cocos 15-20g, Rhizoma Atractylodis Macrocephalae 10-15g, Radix Glycyrrhizae 10-15g, ginger 15-20g, peppermint 10-15g, semen ziziphi spinosae 20-25g, Radix Polygalae 15-20g, donkey-hide gelatin 10-15g, Radix Paeoniae Alba 10-15g, Rhizoma Chuanxiong 10-15g, Radix Notoginseng powder 10-15g and American Ginseng 10-15g.
Preferably, antipsychotics is Risperidone, Quetiapine, Olanzapine, Ziprasidone and Aripiprazole in step (3) One of.
Preferably, mood stabilizers are one of lithium carbonate, sodium vedproate piece and valproic acid magnesium sheet in step (3).
Preferably, step (3) mesocrany Neural stem cell instrument is attached most importance to multiple transcranial magnetic stimulation treatment instrument.
It is still not comprehensive enough to the cognition of drugs because patient home's situation is special or patient is after above-mentioned treatment, it can be with It is transferred to the further rehabilitation in rehabilitation lesion, has shrink and family members to participate in helping patient's drug addiction treatment jointly in convalescence.
The present invention has the advantages that the present invention passes through unique then Xu's secret recipe, and combine infusion, acidification urine and traditional Chinese medicine fumigating Patient's body toxin is quickly discharged in steaming method, while repairing because consuming illegal drugs impaired cranial nerve cell, then treated by psychotherapy, It can effectively release heart addiction, help the drug addiction patient later period that can obtain better rehabilitation, improve preventing suction again rate；The present invention is a kind of fast Fast toxin expelling, toxin expelling is thorough, and treatment is comprehensive, MDT multidisciplinary synthesis cure curative for effect.
Specific embodiment
In order to make content of the present invention easily facilitate understanding, the present invention will be further described for following instance, but It is not used to limit the scope of the present invention.
Embodiment 1
Clock so-and-so, male, 36 years old, people from Guizhou was sensitive more with well-known figure's language without foundation because repeated intermittent sucks k powder (ketamine) 9 years It doubts, depressed January was admitted to hospital on March 5th, 2018.Patient starts to suck k powder under 2009 friends Nian Shi lure, once repeatedly Drug rehabilitation, each personal integrity is not inhaled the time and is not grown, because heart addiction causes to suck repeatedly, about 0.3 gram of each pipette or so, and repetition one in 3 to 4 days It is secondary.Frequent micturition, urgent urination are caused, urodynia is had a stomachache, nasal obstruction.Before one month, thinks that someone is discussing oneself, say oneself malicious remark, say and often think Wife is not loyal to oneself.It is listless when being admitted to hospital, it is depressed, it is demoralized, it is bored with life, it is believed that oneself be one tired It is superfluous, there is suicidal thought, feel uncomfortable in chest, epigastric discomfort, diarrhea, nervous, tongue nature is light red, the micro- Huang of tongue fur, bitter taste, wiry and rolling pulse.Enter Coherence check is improved after institute；
First by Traditional Chinese medicinal prescription it is clearing heat and detoxicating, Traditional Chinese medicinal prescription be by radix bupleuri 23g, Radix Paeoniae Alba 18g, Fructus Aurantii 22g, radix glycyrrhizae preparata 19g, Rhizoma Et Radix Notopterygii 25g, rhizoma corydalis 15g and monkshood 18g high fire decoct 40min, add datura flower 5g, 10g parts of the coptis, Radix Astragali 18g, Radix Angelicae Sinensis 20g, RHIIZOMA DIOSCOREAE from Henan of China 120g, five 10g parts of spirits, cow-bezoar 50g, scorpio 3g, deer horn glue 15g, unipods golden pheasant 9g, 10g parts of Radix Curcumae and olibanum 15g High fire decocts 30min, and last small fire decocts 15min, takes 300ml supernatant A, then small fire is decocted again by the above-mentioned Chinese medicine decocted 30min is boiled, 300ml supernatant B is taken, supernatant A and supernatant B are then mixed into acquisition, and combine sodium chloride Jia Ao meter Azoles intravenous infusion, acidification urine and herbal fumigation method is drawn to exclude vivotoxin, traditional Chinese medicine ingredients include: Radix Astragali in herbal fumigation method 19g, root of fangji 15g, Rhizoma Atractylodis Macrocephalae 15g, ramulus cinnamomi 20g, Radix Paeoniae Alba 20g, Radix Glycyrrhizae 10g, pawpaw 34g, Rhizoma Et Radix Notopterygii 20g, safflower 15g, peach kernel 10g, Radix bupleuri 15g, Radix Curcumae 20g, Radix Angelicae Sinensis 20g and ramulus mori 15g；Then Risperidone is given, escitalopram is oral, once a day, together When to give patient's Piracetam oral, improve its cognitive function, gangliosides 40mg/ days, and be aided with traditional Chinese herbal decoction, Chinese medicine Traditional Chinese medicine ingredients are by weight in decoction are as follows: Radix Angelicae Sinensis 15g, radix bupleuri 20g, Poria cocos 15g, Rhizoma Atractylodis Macrocephalae 14g, Radix Glycyrrhizae 13g, ginger 19g, peppermint 15g, semen ziziphi spinosae 23g, Radix Polygalae 20g, donkey-hide gelatin 15g, Radix Paeoniae Alba 10g, Rhizoma Chuanxiong 15g, Radix Notoginseng powder 10g and American Ginseng 15g；Restore patient by Damage cranial nerve cell function；
After disease amelioration, then pass through the cranial nerve cell of transcranial magnetic stimulation treatment patient, while above-mentioned treatment, according to poison The motivation that addiction patient consumes illegal drugs takes targetedly psychotherapy, motivation intensive treatment, cognitive behavioral therapy, reduces injury Technology, family marriage treatment, individual drug rehabilitation consulting, group's drug rehabilitation consulting and meditation technology, make drug addiction patient from the muddled of drug rehabilitation Stage gradually takes action the stage successively excessively to the preparation stage is pondered, the consolidation phase, termination phase；
Again after family psychotherapy and individual mind treatment, so that drug addiction patient is preferably re-established interpersonal relationships, establish Home duties sense, social responsibility；Hospitalization half a month, all diseases, which are known, removes, physical recovery to normal condition.Following the service Chinese mugwort department after discharge Citalopram is more than the moon, and nearest follow-up is energetic.
Embodiment 2
Chen, female, 43 years old, people from Foochow, intermittence sucked methamphetamine 8 years, was admitted to hospital within terrified 2 weeks with suspicious self-accusation.Began from 2010, Patient sucks methamphetamine, and about 0.2 to 0.3 gram of every secondary amounts differs, and is spaced 3 to 5 days, sucks repeatedly, have glad pleasant feeling, when sucking After length, irritability is irascible, thinks that someone's next door discusses oneself, drinks water worried recently without foundation often, is afraid of that someone puts in poison, female It softly one is cried behind, it is terrified, it chats people, oneself is not a good woman, be not so good as others.When people institute, spiritual impotence wastes, One's cheekbones stood out and one's eyes were sunken, complexion is dark, and speech does not cut meaning, and amnesia is demoralized, hypothymergasia, when every afternoon 4 about it is vexed uncomfortable in chest on time, It crys endlessly, blood pressure up to 240/148mmHg.Tentative diagnosis is to use psychoactive drug substance caused by mental disorder.Press down in anxiety Strongly fragrant state, that is, improve coherence check；
It is clearing heat and detoxicating by Traditional Chinese medicinal prescription first, radix bupleuri 23g, Radix Paeoniae Alba 22g, Fructus Aurantii 20g, radix glycyrrhizae preparata 22g, Rhizoma Et Radix Notopterygii 23g, rhizoma corydalis 18g and monkshood 18g high fire decoct 40min, add datura flower 3g, 5g parts of the coptis, Radix Astragali 16g, Radix Angelicae Sinensis 20g, RHIIZOMA DIOSCOREAE from Henan of China 18g, Five 15g parts of spirits, cow-bezoar 5g, scorpio 8g, deer horn glue 15g, unipods golden pheasant 5g, Radix Curcumae 10g and olibanum 15g high fire decoct 30min, finally Small fire decocts 15min, takes 300ml supernatant A, then small fire decocts 30min again by the above-mentioned Chinese medicine decocted, takes 300ml Then supernatant A and supernatant B are mixed acquisition by supernatant B；And add salt in conjunction with monosialotetrahexose ganglioside sodium The quiet Shang of water, acidification urine and herbal fumigation method exclude vivotoxin, and traditional Chinese medicine ingredients include: Radix Astragali in herbal fumigation method 18g, root of fangji 15g, Rhizoma Atractylodis Macrocephalae 15g, ramulus cinnamomi 20g, Radix Paeoniae Alba 15g, Radix Glycyrrhizae 13g, pawpaw 34g, Rhizoma Et Radix Notopterygii 20g, safflower 14g, peach kernel 10g, Radix bupleuri 18g, Radix Curcumae 19g, Radix Angelicae Sinensis 18g and ramulus mori 17g；Then think of Citalopram, Risperidone, bluish dogbane, vitamin B compound are given It is oral, once a day, not timing Lorazepam sublingual administration；
It 3 days after clothes, is emotionally stable, anxiety and sobbing periodically in the afternoon do not occur, continues to maintain former Regimen Chemotherapy in hospital, give simultaneously Patient's Piracetam is oral, improves its cognitive function, and be aided with traditional Chinese herbal decoction, and traditional Chinese medicine ingredients are by weight in traditional Chinese herbal decoction Are as follows: Radix Angelicae Sinensis 18g, radix bupleuri 19g, Poria cocos 15g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 13g, ginger 19g, peppermint 13g, semen ziziphi spinosae 25g, Radix Polygalae 15g, Donkey-hide gelatin 15g, Radix Paeoniae Alba 10g, Rhizoma Chuanxiong 14g, Radix Notoginseng powder 11g and American Ginseng 12g；Restore patient and is damaged cranial nerve cell function；
After disease amelioration, then pass through the cranial nerve cell of transcranial magnetic stimulation treatment patient, while above-mentioned treatment, according to poison The motivation that addiction patient consumes illegal drugs takes targetedly psychotherapy, motivation intensive treatment, cognitive behavioral therapy, reduces injury Technology, family marriage treatment, individual drug rehabilitation consulting, group's drug rehabilitation consulting and meditation technology, make drug addiction patient from the muddled of drug rehabilitation Stage gradually takes action the stage successively excessively to the preparation stage is pondered, the consolidation phase, termination phase；
Again after family psychotherapy and individual mind treatment, allows patient that can preferably re-establish interpersonal relationships, found a family The sense of duty, social responsibility；It is hospitalized 31 days altogether, physical rehabilitation to normal condition, blood pressure stabilization is above or below 146/92mmHg.
The foregoing is merely presently preferred embodiments of the present invention, all equivalent changes done according to scope of the present invention patent with Modification, is all covered by the present invention.

Claims (9)

1. a kind of drug rehabilitation therapy for synthetic drug, it is characterised in that: the following steps are included:
(1) quick toxin expelling: it is the 1st week, clearing heat and detoxicating by Traditional Chinese medicinal prescription, and infusion, acidification urine and herbal fumigation method are combined, Vivotoxin is thoroughly rapidly excluded by the liver of drug addiction patient, kidney, blood and skin；
(2) promote cranial nerve cell functional rehabilitation: the 2-3 weeks, giving drug addiction patient rush cognition drug improved its cognitive function, together When give gangliosides 40mg/ days, and be aided with traditional Chinese herbal decoction, restore drug addiction patient and be damaged cranial nerve cell function；
(3) it controls mental symptom: the 2-4 weeks, giving haloperidol 5-10mg intramuscular injection, anti-essence according to drug addiction patient mental's symptom Refreshing medicine is oral, after the disappearance of its mental symptom, deactivates antipsychotics then, to the drug addiction patient for the disturbance of emotion occur to Mood stabilizers, depression and anti anxiety agent object are given, after disease amelioration, then passes through the brain of transcranial magnetic stimulation treatment patient Nerve cell；
(4) it psychotherapy: while above-mentioned treatment, according to the motivation that drug addiction patient consumes illegal drugs, takes targetedly psychological Treatment, motivation intensive treatment, cognitive behavioral therapy, reduction injury technology, family marriage treatment, individual drug rehabilitation consulting, group's ring Poison consulting and meditation technology make drug addiction patient from the muddled stage of drug rehabilitation gradually successively excessively to the preparation stage is pondered, rank of taking action Section, consolidation phase, termination phase；
(5) preventing suction again is treated: after above-mentioned treatment, drug addiction patient is because of the variation of Neurobiology caused by consuming illegal drugs, substantially It is addressed, then after family psychotherapy and individual mind treatment, drug addiction patient is enable preferably to re-establish interpersonal relationships, Found a family the sense of duty, social responsibility.
2. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: described in step (1) Traditional Chinese medicinal prescription is by radix bupleuri 18-25g, Radix Paeoniae Alba 18-25g, Fructus Aurantii 18-25g, radix glycyrrhizae preparata 18-25g, Rhizoma Et Radix Notopterygii 20-25g, rhizoma corydalis 15-20g and monkshood 15-20g high fire decoct 40min, add datura flower 3-8g, coptis 5-10g, Radix Astragali 15-20g, Radix Angelicae Sinensis 15- 20g, RHIIZOMA DIOSCOREAE from Henan of China 15-20g, five spirit 5-10g, cow-bezoar 5-10g, scorpio 3-8g, deer horn glue 10-15g, unipods golden pheasant 5-10g, Radix Curcumae 10-15g and olibanum 15-20g high fire decoct 30min, and last small fire decocts 15min, takes 300ml supernatant A, then decocted above-mentioned Small fire decocts 30min to the Chinese medicine boiled again, takes 300ml supernatant B, supernatant A and supernatant B are then mixed acquisition.
3. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: infusion in step (1) Used infusion solution is nutrition infusion.
4. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: described in step (1) Traditional Chinese medicine ingredients are by weight in herbal fumigation method are as follows: Radix Astragali 15-20g, root of fangji 10-15g, Rhizoma Atractylodis Macrocephalae 15-20g, ramulus cinnamomi 15-20g, Radix Paeoniae Alba 15-20g, Radix Glycyrrhizae 10-15g, pawpaw 30-35g, Rhizoma Et Radix Notopterygii 15-20g, safflower 10-15g, peach kernel 10-15g, radix bupleuri 15-20g, Radix Curcumae 15-20g, Radix Angelicae Sinensis 15-20g and ramulus mori 15-20g.
5. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: promote to recognize in step (2) Know that drug is one of huperzine, Piracetam and Cerebrolysin.
6. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: described in step (2) Traditional Chinese medicine ingredients are by weight in traditional Chinese herbal decoction are as follows: Radix Angelicae Sinensis 15-20g, radix bupleuri 18-23g, Poria cocos 15-20g, Rhizoma Atractylodis Macrocephalae 10-15g, Radix Glycyrrhizae 10-15g, ginger 15-20g, peppermint 10-15g, semen ziziphi spinosae 20-25g, Radix Polygalae 15-20g, donkey-hide gelatin 10-15g, Radix Paeoniae Alba 10-15g, river Rhizome of chuanxiong 10-15g, Radix Notoginseng powder 10-15g and American Ginseng 10-15g.
7. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: anti-essence in step (3) Refreshing medicine is one of Risperidone, Quetiapine, Olanzapine, Ziprasidone and Aripiprazole.
8. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: mental state in step (3) Stabilizer is one of lithium carbonate, sodium vedproate piece and valproic acid magnesium sheet.
9. a kind of drug rehabilitation therapy for synthetic drug according to claim 1, it is characterised in that: step (3) mesocrany magnetic Stimulating instrument is to repeat transcranial magnetic stimulation treatment instrument.
CN201811110306.7A 2018-09-21 2018-09-21 A kind of drug rehabilitation therapy for synthetic drug Withdrawn CN109010695A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811110306.7A CN109010695A (en) 2018-09-21 2018-09-21 A kind of drug rehabilitation therapy for synthetic drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811110306.7A CN109010695A (en) 2018-09-21 2018-09-21 A kind of drug rehabilitation therapy for synthetic drug

Publications (1)

Publication Number Publication Date
CN109010695A true CN109010695A (en) 2018-12-18

Family

ID=64618102

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811110306.7A Withdrawn CN109010695A (en) 2018-09-21 2018-09-21 A kind of drug rehabilitation therapy for synthetic drug

Country Status (1)

Country Link
CN (1) CN109010695A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110420382A (en) * 2019-04-11 2019-11-08 遂宁君珉医院 A kind of poison-removing method of combination Chinese medicine treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110420382A (en) * 2019-04-11 2019-11-08 遂宁君珉医院 A kind of poison-removing method of combination Chinese medicine treatment

Similar Documents

Publication Publication Date Title
CN101874891B (en) Chinese medicinal composition for treating heart-throb and preparation method thereof
CN103859907B (en) Health care pillow for treating insomnia
CN105194631B (en) Treat the Chinese medicine preparation of depression
CN102784319B (en) Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of both qi and yin
CN103784878B (en) Traditional Chinese medicine convulsion-relieving and nerve-calming pills/soup for treating mental disease and preparation method thereof
CN102526677A (en) Chinese medicine foot-massage composition for treating common cold due to wind-cold
CN101422571B (en) Psychosis positive four-step therapeutics series medicine
CN103800888B (en) A kind of Chinese medicine composition treating neurasthenia
CN104983985A (en) Chinese herba preparation for treating depression
CN109010695A (en) A kind of drug rehabilitation therapy for synthetic drug
CN103948888A (en) Traditional Chinese medicinal preparation for treating neurasthenia
CN104435678A (en) Traditional Chinese medicine composition for treating palpitation caused by qi stagnation and blood stasis syndrome
CN110314218A (en) A kind of coptis Wendan Tang and preparation method thereof
CN104383421A (en) Pharmaceutical preparation for treating insomnia and dreaminess
CN104383420A (en) Preparation method of pharmaceutical preparation for treating insomnia and dreaminess
CN104524464A (en) Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation
CN102048982A (en) TCM for treating insomnia
CN102784358A (en) Preparation method of traditional Chinese medicine for treating liver stagnation insomnia
CN103550470B (en) Healthy traditional Chinese medicine for children
CN108743832B (en) Depression-relieving nerve-soothing pillow inner
CN102441103B (en) Medicine for treating insomnia
CN105832996A (en) Traditional Chinese medicine composition for treating hysteria
CN102861289B (en) Chinese medicinal drug addiction stopping and three-hyper lowering capsule
CN102961534A (en) Traditional Chinese medicine composition for treating schizophrenia in stage of attack and preparation method thereof
CN102784302A (en) Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of kidney yin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20181218